What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?

Marta Waliszewska-Prosół; Doga Vuralli; Paolo Martelletti

doi:10.1186/s10194-023-01698-8

What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?

Marta Waliszewska-Prosół
, Doga Vuralli
, Paolo Martelletti

Wrocław Medical University
Gazi University
UnitelmaSapienza University of Rome

Araştırma sonucu: Dergiye katkı › Editöryal

16 Alıntılar (Scopus)

Özet

In this editorial we aim to provide potential therapeutic options in patients who do not benefit from treatment with CGRP(r) monoclonal antibodies. Based on current real-life studies and analysis of practical and economic aspects, we will analyze the potential benefits of changing CGRP-targeted treatment.

Orijinal dil	İngilizce
Makale numarası	163
Dergi	Journal of Headache and Pain
Hacim	24
Basın numarası	1
DOI'lar	https://doi.org/10.1186/s10194-023-01698-8
Yayın durumu	Yayınlandı - Ara 2023
Harici olarak yayınlandı	Evet

Belgeye Erişim

10.1186/s10194-023-01698-8

Diger dosyalar ve linkler

Link to publication in Scopus

Bundan alıntı yap

@article{2d4fef4a5118434fa75551afa2f5249c,

title = "What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?",

abstract = "In this editorial we aim to provide potential therapeutic options in patients who do not benefit from treatment with CGRP(r) monoclonal antibodies. Based on current real-life studies and analysis of practical and economic aspects, we will analyze the potential benefits of changing CGRP-targeted treatment.",

keywords = "CGRP, Combination, Gepants, Responders, Switching",

author = "Marta Waliszewska-Pros{\'o}{\l} and Doga Vuralli and Paolo Martelletti",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

doi = "10.1186/s10194-023-01698-8",

language = "English",

volume = "24",

journal = "Journal of Headache and Pain",

issn = "1129-2369",

publisher = "BioMed Central Ltd",

number = "1",

}

TY - JOUR

T1 - What to do with non-responders to CGRP(r) monoclonal antibodies

T2 - switch to another or move to gepants?

AU - Waliszewska-Prosół, Marta

AU - Vuralli, Doga

AU - Martelletti, Paolo

PY - 2023/12

Y1 - 2023/12

N2 - In this editorial we aim to provide potential therapeutic options in patients who do not benefit from treatment with CGRP(r) monoclonal antibodies. Based on current real-life studies and analysis of practical and economic aspects, we will analyze the potential benefits of changing CGRP-targeted treatment.

AB - In this editorial we aim to provide potential therapeutic options in patients who do not benefit from treatment with CGRP(r) monoclonal antibodies. Based on current real-life studies and analysis of practical and economic aspects, we will analyze the potential benefits of changing CGRP-targeted treatment.

KW - CGRP

KW - Combination

KW - Gepants

KW - Responders

KW - Switching

UR - https://www.scopus.com/pages/publications/85178396081

U2 - 10.1186/s10194-023-01698-8

DO - 10.1186/s10194-023-01698-8

M3 - Editorial

C2 - 38053061

AN - SCOPUS:85178396081

SN - 1129-2369

VL - 24

JO - Journal of Headache and Pain

JF - Journal of Headache and Pain

IS - 1

M1 - 163

ER -

What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?

Özet

Belgeye Erişim

Diger dosyalar ve linkler

Parmak izi

Bundan alıntı yap